VEGF is an essential molecule for glomerular structuring - PubMed (original) (raw)

Review

VEGF is an essential molecule for glomerular structuring

Y Kitamoto et al. Nephrol Dial Transplant. 2002.

Abstract

Since glomerular development is regarded as angiogenesis/vasculogenesis, there should be angiogenic cytokines which mediate glomerulogenesis. In the developing kidney, messages of vascular endothelial growth factor (VEGF) and its receptors are expressed in epithelial and endothelial cells of the glomerulus, respectively. In vivo, suppression of VEGF activity by neutralizing antibody seriously interrupts glomerulogenesis. Typically, there are no endothelial cells in the abnormal glomerulus. Structural changes of the glomerulus were clear by observing vascular castings of renal vessels. Although structures of arteries and arterioles were not impaired, the capillary lumen of the glomerulus was completely lost or interrupted halfway through development. It is concluded that VEGF is secreted from the Bowman's capsule, and stimulates endothelial or endothelial progenitor cells in a paracrine fashion to form the glomerulus.

PubMed Disclaimer

Similar articles

• Vascular endothelial growth factor is an essential molecule for mouse kidney development: glomerulogenesis and nephrogenesis.
  Kitamoto Y, Tokunaga H, Tomita K. Kitamoto Y, et al. J Clin Invest. 1997 May 15;99(10):2351-7. doi: 10.1172/JCI119416. J Clin Invest. 1997. PMID: 9153276 Free PMC article.
• Loss of the VEGF(164) and VEGF(188) isoforms impairs postnatal glomerular angiogenesis and renal arteriogenesis in mice.
  Mattot V, Moons L, Lupu F, Chernavvsky D, Gómez RA, Collen D, Carmeliet P. Mattot V, et al. J Am Soc Nephrol. 2002 Jun;13(6):1548-60. doi: 10.1097/01.asn.0000013925.19218.7b. J Am Soc Nephrol. 2002. PMID: 12039984
• [VEGF is an essential molecule for glomerular endothelial cells and its excretion in urine might be a unique marker of glomerular injury].
  Kitamoto Y, Tokunaga H, Miyamoto K, Tomita K. Kitamoto Y, et al. Rinsho Byori. 2000 Jun;48(6):485-90. Rinsho Byori. 2000. PMID: 10897664 Review. Japanese.
• Glomerular endothelial cells are maintained by vascular endothelial growth factor in the adult kidney.
  Kitamoto Y, Takeya M, Tokunaga H, Tomita K. Kitamoto Y, et al. Tohoku J Exp Med. 2001 Sep;195(1):43-54. doi: 10.1620/tjem.195.43. Tohoku J Exp Med. 2001. PMID: 11780723
• Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
  Jośko J, Gwóźdź B, Jedrzejowska-Szypułka H, Hendryk S. Jośko J, et al. Med Sci Monit. 2000 Sep-Oct;6(5):1047-52. Med Sci Monit. 2000. PMID: 11208453 Review.

Cited by

• Phase 1 study of aflibercept administered subcutaneously to patients with advanced solid tumors.
  Tew WP, Gordon M, Murren J, Dupont J, Pezzulli S, Aghajanian C, Sabbatini P, Mendelson D, Schwartz L, Gettinger S, Psyrri A, Cedarbaum JM, Spriggs DR. Tew WP, et al. Clin Cancer Res. 2010 Jan 1;16(1):358-66. doi: 10.1158/1078-0432.CCR-09-2103. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028764 Free PMC article. Clinical Trial.
• In vivo maturation of functional renal organoids formed from embryonic cell suspensions.
  Xinaris C, Benedetti V, Rizzo P, Abbate M, Corna D, Azzollini N, Conti S, Unbekandt M, Davies JA, Morigi M, Benigni A, Remuzzi G. Xinaris C, et al. J Am Soc Nephrol. 2012 Nov;23(11):1857-68. doi: 10.1681/ASN.2012050505. Epub 2012 Oct 18. J Am Soc Nephrol. 2012. PMID: 23085631 Free PMC article.
• Targeted therapies for lung cancer: clinical experience and novel agents.
  Larsen JE, Cascone T, Gerber DE, Heymach JV, Minna JD. Larsen JE, et al. Cancer J. 2011 Nov-Dec;17(6):512-27. doi: 10.1097/PPO.0b013e31823e701a. Cancer J. 2011. PMID: 22157296 Free PMC article. Review.
• Anti-glomerular basement membrane glomerulonephritis following nintedanib for idiopathic pulmonary fibrosis: a case report.
  Ismail I, Nigam S, Parnham A, Srinivasa V. Ismail I, et al. J Med Case Rep. 2017 Aug 6;11(1):214. doi: 10.1186/s13256-017-1384-2. J Med Case Rep. 2017. PMID: 28779751 Free PMC article.
• Uteroplacental insufficiency affects kidney VEGF expression in a model of IUGR with compensatory glomerular hypertrophy and hypertension.
  Baserga M, Bares AL, Hale MA, Callaway CW, McKnight RA, Lane PH, Lane RH. Baserga M, et al. Early Hum Dev. 2009 Jun;85(6):361-7. doi: 10.1016/j.earlhumdev.2008.12.015. Epub 2009 Feb 1. Early Hum Dev. 2009. PMID: 19188030 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems